POLYAMYNA
Polyamyna helps to develop next-generation antimicrobial technologies to prevent infections caused by deadly pathogens, especially ESKAPE bacteria. Their products includes advanced antimicrobial technologies and disinfectant technology. Their customer can contact them through online.
POLYAMYNA
Industry:
Biotechnology Life Science Nanotechnology
Founded:
2017-01-01
Address:
St. John's, Newfoundland, Canada
Country:
Canada
Website Url:
http://www.polyamyna.ca
Total Employee:
11+
Status:
Active
Total Funding:
1.73 M USD
Technology used in webpage:
SPF Euro DMARC Google Apps For Business GoDaddy DNS Pexels Imunify360 Choopa
Similar Organizations
Eikon Therapeutics
Eikon Therapeutics is a biopharmaceutical company that develops live-cell resolution microscopy and engineering for drug discovery.
Iroko Pharmaceuticals
Iroko Pharmaceuticals is a global specialty pharmaceutical company dedicated to advancing the science of analgesia.
Kytopen
Kytopen developer of a cell therapy platform for non-viral delivery of molecules into hard-to-transfect immune cells.
Longevity Biotech
Longevity Biotech develops a new class of therapeutics via artificial protein technology that focuses on pharmaceutical preparation.
Navrogen
Navrogen is a biopharmaceutical company focused on the targeted treatment of cancer.
nference
nference is an Artificial Intelligence (AI)-powered venture creation engine
Renovacor
Renovacor is a biopharmaceutical company that focuses on developing transformative gene therapy‑based treatments for cardiovascular disease.
Vivodyne
Vivodyne develops an automated robotic system that discovers life-changing drugs and cellular therapies.
Current Employees Featured
Founder
Investors List
Sustainable Development Technology Canada
Sustainable Development Technology Canada investment in Seed Round - Polyamyna
National Research Council of Canada Industrial Research Assistance Program
National Research Council of Canada Industrial Research Assistance Program investment in Grant - Polyamyna
Government of Newfoundland and Labrador
Government of Newfoundland and Labrador investment in Grant - Polyamyna
Genesis
Genesis investment in Pre Seed Round - Polyamyna
Official Site Inspections
http://www.polyamyna.ca Semrush global rank: 9.79 M Semrush visits lastest month: 378
- Host name: c14.tmdcloud.asia
- IP address: 45.77.43.41
- Location: Singapore Singapore
- Latitude: 1.2929
- Longitude: 103.8547
- Timezone: Asia/Singapore
- Postal: 00
More informations about "Polyamyna"
Supporting Health Innovation Through Research and Development ...
Oct 31, 2023 Through innovative research and development, we are able to improve health care delivery and accessibility while guaranteeing positive health outcomes well into the future.” …See details»
Newfoundland scientists find a new way to fight …
Nov 25, 2018 The World Health Organization classes those bacteria — or superbugs — as one of the biggest threats to global health, and Polyamyna Nanotech of St. John's hopes to fight resistance by ...See details»
Polyamyna - Crunchbase Company Profile & Funding
Polyamyna develops advanced antimicrobial technologies to combat multi-extensive and pan-drug-resistant pathogenic microorganisms.See details»
Polyamyna Nanotech Inc. - econext
We at Polyamyna Nanotech Inc. (PNI), endeavor to develop next-generation antimicrobial coatings to prevent hospital-acquired infections (HAI), eventually striving to address global …See details»
Polyamyna Nanotech Inc - new live techNL createdByMoh …
Polyamyna is developing advanced antimicrobial technologies to combat multi-drug resistant, extensive drug-resistant and pan-drug-resistant pathogenic microorganisms.See details»
Supporting Research and Development to Improve Patient Safety
Feb 20, 2019 The Honourable Christopher Mitchelmore, Minister of Tourism, Culture, Industry and Innovation, today toured Polyamyna Nanotech Inc.’s laboratory space at Marine Institute, …See details»
Polyamyna Nanotech Inc - LinkedIn
Polyamyna Nanotech Inc | 675 followers on LinkedIn. Polyamyna is developing advanced antimicrobial technologies to combat multi-drug resistant, extensive drug-resistant and pan …See details»
Polyamyna Nanotech Inc. | Technology Solutions
We at Polyamyna Nanotech Inc. (PNI), endeavor to develop next-generation antimicrobial technologies to prevent infections caused by deadly pathogens.See details»
Polyamyna Company Profile 2024: Valuation, Funding & Investors
Information on valuation, funding, cap tables, investors, and executives for Polyamyna. Use the PitchBook Platform to explore the full profile.See details»
Polyamyna Nanotech, Inc.: Drug pipelines, Patents, Clinical trials ...
Explore Polyamyna Nanotech, Inc. with its drug pipeline, therapeutic area, technology platform, .See details»
Local Company Helping Combat the Spread of COVID-19
Apr 30, 2021 The Provincial Government contributed a non-repayable investment of $129,000 to Polyamyna Nanotech, as part of the company’s certification process for Health Canada and …See details»
Polyamyna - Funding, Financials, Valuation & Investors
Polyamyna develops advanced antimicrobial technologies to combat multi-extensive and pan-drug-resistant pathogenic microorganisms.See details»
Polyamyna - Products, Competitors, Financials, Employees, …
Polyamyna specializes in advanced antimicrobial technologies within the healthcare sector. The company develops products such as microbicidal coatings, antimicrobial fabrics, and adjuvant …See details»
Polyamyna Preps for Clinical Trials - Entrevestor
May 13, 2021 St. John’s-based disinfectant maker Polyamyna Nanotech has inked a deal with Eastern Health to run clinical trials of its product once it receives Health Canada approval. …See details»
Polyamyna Nanotech Inc. | Technology Solutions
We at Polyamyna Nanotech Inc. (PNI), endeavor to develop next-generation antimicrobial technologies to prevent infections caused by deadly pathogens.See details»
Polyamyna - Contacts, Employees, Board Members, Advisors
Polyamyna develops advanced antimicrobial technologies to combat multi-extensive and pan-drug-resistant pathogenic microorganisms.See details»
Robert Hoyles - Vice President - Polyamyna Nanotech Inc | LinkedIn
Vice President | Bachelor of Applied Science (B.A.Sc.) · Experience: Polyamyna Nanotech Inc · Education: Memorial University of Newfoundland · Location: Canada · 500+ connections on …See details»
Biological Evaluation of Antimicrobial Materials - mitacs.ca
Bacterial infections spread from one person to another person by means of a simple touch of contaminated surfaces in healthcare units. These infections have become untreatable to most …See details»
Vanishall · Polyamyna Nanotech Inc. · 495 Water Street
Vanishall is a drug product manufactured by POLYAMYNA NANOTECH INC., according to the data provided by Health Canada. The update date is April 8, 2021.See details»
Ministry of Mining and Critical Minerals - gov.bc.ca
Dec 5, 2024 Learn about the critical minerals of British Columbia. Mineral Exploration and Mining Over 30,000 people are employed in mineral exploration, mining and related sectors in B.C. …See details»